Reproducibility of Proximal Isovelocity Surface Area, Vena Contracta, and Regurgitant Jet Area for Assessment of Mitral Regurgitation Severity

Size: px
Start display at page:

Download "Reproducibility of Proximal Isovelocity Surface Area, Vena Contracta, and Regurgitant Jet Area for Assessment of Mitral Regurgitation Severity"

Transcription

1 JACC: CARDIOVASCULAR IMAGING VOL. 3, NO. 3, BY THE AMERICAN COLLEGE OF CARDIOLOGY FOUNDATION ISSN X/10/$36.00 PUBLISHED BY ELSEVIER INC. DOI: /j.jcmg Reproducibility of Proximal Isovelocity Surface Area, Vena Contracta, and Regurgitant Jet Area for Simon Biner, MD,* Asim Rafique, MD, Farhad Rafii, MD, Kirsten Tolstrup, MD, Omid Noorani, MS, Takahiro Shiota, MD, Swaminatha Gurudevan, MD, Robert J. Siegel, MD Tel Aviv, Israel; and Los Angeles, California OBJECTIVES The aim of this study was to evaluate the interobserver agreement of proximal isovelocity surface area (PISA) and vena contracta (VC) for differentiating severe from nonsevere mitral regurgitation (MR). BACKGROUND Recommendation for MR evaluation stresses the importance of VC width and effective regurgitant orifice area by PISA measurements. Reliable and accurate assessment of MR is important for clinical decision making regarding corrective surgery. We hypothesize that color Doppler-based quantitative measurements for classifying MR as severe versus nonsevere may be particularly susceptible to interobserver agreement. METHODS The PISA and VC measurements of 16 patients with MR were interpreted by 18 echocardiologists from 11 academic institutions. In addition, we obtained quantitative assessment of MR based on color flow Doppler jet area. RESULTS The overall interobserver agreement for grading MR as severe or nonsevere using qualitative and quantitative parameters was similar and suboptimal: 0.32 (95% confidence interval [CI]: 0.1 to 0.52) for jet area based MR grade, 0.28 (95% CI: 0.11 to 0.45) for VC measurements, and 0.37 (95% CI: 0.16 to 0.58) for PISA measurements. Significant univariate predictors of substantial interobserver agreement for: 1) jet area based MR grade was functional etiology (p 0.039); 2) VC was central MR (p 0.013) and identifiable effective regurgitant orifice (p 0.049); and 3) PISA was presence of a central MR jet (p 0.003), fixed proximal flow convergence (p 0.025), and functional etiology (p 0.049). Significant multivariate predictors of raw interobserver agreement 80% included: 1) for VC, identifiable effective regurgitant orifice (p 0.035); and 2) for PISA, central regurgitant jet (p 0.02). CONCLUSIONS The VC and PISA measurements for distinction of severe versus nonsevere MR are only modestly reliable and associated with suboptimal interobserver agreement. The presence of an identifiable effective regurgitant orifice improves reproducibility of VC and a central regurgitant jet predicts substantial agreement among multiple observers of PISA assessment. (J Am Coll Cardiol Img 2010;3:235 43) 2010 by the American College of Cardiology Foundation From the *Division of Cardiology, Tel Aviv Sourasky Medical Center, Tel Aviv, Israel; Division of Cardiology, Cedars-Sinai Medical Center; Department of Internal Medicine, Kaiser Permanente; and Department of Biomathematics, University of California, Los Angeles, Los Angeles, California. Manuscript received May 14, 2009; revised manuscript received September 22, 2009, accepted September 28, 2009.

2 236 JACC: CARDIOVASCULAR IMAGING, VOL. 3, NO. 3, 2010 American Society of Echocardiography guideline recommendations for the evaluation of mitral regurgitation (MR) severity include assessment of color flow Doppler (CFD) regurgitant jet area and quantification of MR by vena contracta (VC) and by effective regurgitant orifice area (EROA) using proximal isovelocity surface area (PISA) (1,2). A reproducible method for assessment of MR severity is important for the management of patients with MR. Visualization of the regurgitant jet area in the left atrium provides a fast assessment of the shape, size, and direction of the regurgitant jet and a qualitative See page 244 ABBREVIATIONS AND ACRONYMS CFD color flow Doppler EROA effective regurgitant orifice area MR mitral regurgitation PISA proximal isovelocity surface area VC vena contracta evaluation of its severity, whereas assessment of VC and PISA requires meticulous attention to technical details both at image acquisition and during actual measurements (Figs. 1A and 1B) (2 5). Echocardiographic research laboratories have demonstrated that PISA and VC are accurate for MR assessment and have good interobserver agreement (3,6 11). However, the etiology of MR, the mitral valve morphology, and the regurgitant jet characteristics further complicate the assessment of MR (2,5,6). In addition, the dynamic nature of MR and pansystolic changes in VC and proximal flow convergence rate may also lead to a considerable temporal variation of both the VC width and the 2-dimensional PISA radius throughout systole, causing uncertainty among echocardiogram readers about which particular frame to choose for measurement (7). Therefore, we hypothesized that quantitative measurements of PISA and VC for classifying MR as severe versus nonsevere will have considerable interobserver agreement among clinical echocardiologists. The primary aim of this study was to evaluate the interobserver agreement of quantitative MR assessment by PISA and VC for differentiating severe from nonsevere MR. In addition, we also evaluated the reproducibility of qualitative CFD-based MR jet area as it is frequently used in clinical settings to help identify severity of MR. METHODS Patients. Interobserver agreement of jet area based assessment of MR severity, PISA, and VC was evaluated using transthoracic echocardiograms of Figure 1. Measurement of MR PISA Radius and VC Width (A) A magnified 4-chamber view was used to measure proximal isovelocity surface area (PISA) radius. The Nyquist limit was adjusted in each case to provide optimal visualization of the mitral regurgitation (MR) proximal flow convergence. The PISA radius is measured between the aliasing line of the isovelocity surface and the level of mitral regurgitant orifice. (B) A magnified parasternal long axis view was used to measure vena contracta (VC) width. To obtain an optimal VC, the transducer was sometimes angulated out of the standard imaging plane so as to identify simultaneously the 3 components including: the area of proximal flow acceleration, the VC, and the downstream expansion of the mitral regurgitation jet. The VC width (effective regurgitant orifice) is the dimension of the neck between proximal flow convergence and flow expansion in receiving chamber. 16 consecutive patients referred to Cedars Sinai Medical Center for possible surgical correction of MR. All patients had a history of effort intolerance or were asymptomatic with left ventricular systolic dysfunction. The focus of the assessment was the classification of MR into severe versus nonsevere categories to identify appropriate candidates for mitral valve surgery. The Cedars Sinai Medical Center Institutional Review Board approved this study. Interpreters. Eighteen cardiologists with mean 16 (range 2 to 40) years of post-cardiology fellowship experience as echocardiographic specialists (echocardiologists), practicing at 11 different universitybased institutions in the U.S., Japan, and Israel were provided secure Web-based access to relevant echo-

3 JACC: CARDIOVASCULAR IMAGING, VOL. 3, NO. 3, cardiographic images. The influence of institutional standards on interobserver agreement was evaluated by comparing the agreement of the 6 echocardiologists practicing in a single institution to the agreement of the echocardiologists from multiple institutions. Echocardiography. A single trained sonographer with clinical trial research experience performed all studies. A narrow color flow sector width and the least depth were chosen to maximize image resolution. The CFD images of the mitral valve regurgitant jet were acquired in the parasternal long axis, apical 4- and 2-chamber views at a Nyquist limit of 50 to 60 cm/s (2). In addition, proximal flow convergence was recorded using a magnified 4-chamber view, with baseline shift of the Nyquist limit to optimize visualization of flow convergence (2) (Figs. 2A and 2B). All echocardiogram clips (moving images) were available on the Website. There were no still frame images. The reader, however, was able to play the images, stop frame them, magnify them, perform frame-by-frame analysis, as well as take measurements using calibration markings and caliper. All imaging were performed with the ie33 ultrasound system (Phillips Medical Systems, Andover, Massachusetts). As shown in Figures 3A and 3B, VC was acquired on a magnified parasternal long axis view. To image the VC, the transducer was angulated out of the standard imaging planes in an attempt to visualize the area of proximal flow acceleration, the VC, and the downstream expansion of the jet (2). Study parameters. Participants were provided CFD images and were asked to rate the following parameters: 1) MR grade from 1 to 4 based on visual qualitative assessment of the jet area; 2) manual quantitative measurement of VC; and 3) quantitative measurement of PISA radius. If the echocardiologist found a parameter to be uninterpretable, it was noted. According to reported values of PISA radius, the EROA was calculated using the following formula: 2 EROA 2 R PISA V aliasing V max where R PISA is PISA radius (cm), V aliasing is aliasing velocity of the proximal flow convergence (cm/s), and V max is maximal velocity of continuous wave Doppler MR signal (cm/s). Definitions. The MR was graded as severe or nonsevere for each echocardiogram-doppler parameter. MR was considered severe if VC was 7 mm, if EROA was 40 mm 2, or the jet size based grade Figure 2. Limitation of PISA Radius for Assessment of MR Severity (A) Clear definition of the aliasing line of the proximal isovelocity surface area (PISA) is critical for accurate assessment of mitral regurgitation (MR) severity. As shown in this apical 4-chamber view, the aliasing line of the isovelocity surface and the regurgitant orifice are well visualized, therefore reducing the potential overall interobserver variability in the assessment of MR severity. (B) In this apical 4-chamber view, the MR isovelocity surface is readily identifiable; however, precise location of the regurgitant orifice is difficult to judge. This makes the assessment of proximal isovelocity surface area radius less reliable and increases the interobserver variability in the assessment of MR severity. was 3 or 4; MR was considered nonsevere if VC was 6.9 mm, EROA was 39 mm 2, or jet size based assessment graded it as 1 or 2. The MR jet was considered eccentric if it was in close contact with the mitral leaflet behind the regurgitant orifice, and impinged to the medial or lateral wall of the left atrium, whereas central jets were initially directed into the center of the left atrium (2,3). For each patient, temporal variability of PISA radius and VC width were assessed by measuring these parameters frame by frame throughout sys-

4 238 JACC: CARDIOVASCULAR IMAGING, VOL. 3, NO. 3, 2010 Figure 3. Limitation of VC Width for Assessment of MR Severity (A) As shown in this parasternal long axis view, the transition from proximal flow conversion (arrow) to the vena contracta (VC) of mitral regurgitant (MR) jet is visualized facilitating identification of the effective regurgitant orifice. A clearly defined VC neck is essential for reliable assessment of MR severity. (B) In this parasternal long axis view, the transition from the proximal flow conversion to the VC is not well visualized. Consequently, the identification of the effective MR orifice is challenging. No clear VC neck is seen; therefore, this introduces more potential interobserver variability in the assessment of MR severity. tole. We classified PISA and VC as having substantial pansystolic variation if there was greater than a 30% difference between the greatest and smallest values of any 2 different frames of the same cardiac cycle. We classified PISA as nonspherical if the maximal and minimal radius of the proximal flow convergence demonstrated a greater than 30% variation within 1 cardiac cycle. We used a cutoff of 30% to define substantial temporal variability of PISA radius and VC width as well as PISA sphericity to account for a 7% to 8% intraobserver variability of the small-scale measurements in our laboratory. In addition, a 30% difference in these parameters was readily detectable by visual assessment. Figure 3 demonstrates identification of the effective regurgitant orifice, which was defined as visible if the transition of proximal flow convergence to the VC was clearly identifiable. Overall, raw interobserver agreement (percent agreement) of 80% was classified as substantial agreement as this agreement rate was considered clinically adequate by all investigators. Values between 60% and 79% were classified as fair agreement and values below 60% as poor agreement (notably least possible interobserver agreement is 50%, which practically is equivalent to maximal disagreement). Statistical analysis. Statistical analysis was performed with the SPSS 13.0 software (SPSS Inc., Chicago, Illinois). Continuous data are presented as mean SD. Categorical data are presented as absolute number or percentages. The significance level was set at p Interobserver agreement was assessed using the overall raw agreement (percent agreement) and the Fleiss kappa statistic (12). Fleiss multirater kappa coefficient is an agreement rate adjusted for chance rate of agreement, and it was calculated using the Online Kappa Calculator developed by Randolph (13). For this purpose, we used Randolph s multirater variation of Brennan and Prediger s (14) freemarginal kappa. Raw agreement and multirater kappa were calculated for 3 methods (VC, PISA, and jet area based MR severity) in 16 patients by 18 observers and were calculated for each of the individual patients to determine the range of agreement within each method across all participants. Subsequently, cumulative raw agreement and multirate kappa were calculated for 3 study methods in patients with substantial raw agreement ( 80%) and those with suboptimal raw agreement ( 80%). Mean and 95% confidence intervals of multirater kappa were derived for 3 study methods and t test was used for comparison of multirater kappa among various study methods. The MR characteristics thought to be clinically significant were dichotomized. Fisher exact test was used to compare the significance of these predictive parameters on raw agreement of 80% versus 80%. Significant variables were included in the multivariate logistic regression analysis to predict raw agreement 80%. A p value 0.05 was considered significant for all analyses.

5 JACC: CARDIOVASCULAR IMAGING, VOL. 3, NO. 3, Table 1. Baseline Clinical and Echocardiographic Characteristics Patient, n 16 Age, yrs Sex, M/F 9/7 Etiology, degenerative/functional 8/8 MR jet, eccentric/central 10/6 PISA spherical, yes/no 10/6 30% variation of PISA radius, yes/no 7/9 30% variation of VC width, yes/no 7/9 Effective MR orifice identifiable, yes/no 7/9 MR mitral regurgitation; PISA proximal isovelocity surface area; VC vena contracta. RESULTS Baseline characteristics. Clinical and echocardiographic characteristics of 16 patients studied are summarized in Table 1: mean age was years and 56% were men. Eight (50%) had functional MR (6 with ischemic and 2 with dilated cardiomyopathy); 8 cases were degenerative (5 with mitral valve prolapse and 3 with flail leaflet). In 6 patients with functional MR, the jet was central. In all 8 degenerative MR patients and 2 functional MR cases, the jet was eccentric. For both the PISA radius as well as for VC width 7 (5 degenerative and 2 functional MR) cases demonstrated 30% frameby-frame variability, whereas in the rest of the cases, the variability in these parameters was not substantial. The effective regurgitant orifice in the parasternal long axis view was visualized in 7 other cases (Fig. 2A). Prevalence of severe MR. MR severity based on jet area was deemed interpretable by readers in 273 of 288 (95%) instances, whereas VC and PISA were interpreted in 206 of 288 (72%) and 207 of 288 (72%), respectively (p 0.001). Table 2 shows the proportion of observers who rated MR as severe according to various assessment methods in each patient. Using the parameter of jet area, echocardiologists graded MR as severe in 169 of 273 (62%) instances: using VC, MR was graded as severe in 74 of 206 (36%); and using PISA, measurements were consistent with severe MR in 85 of 207 (41%) times (p 0.001). Interobserver agreement. Overall interobserver agreement on the classification of MR as severe or nonsevere was only fair for each of the study parameters. Raw agreement and kappa coefficient were: 75 16% and 0.32 (95% confidence interval [CI]: 0.12 to 0.52), respectively, for jet area based MR grade, 0.28 (95% CI: 0.11 to 0.45) and 75 Table 2. The Rate of Classification of MR as Severe by 18 Observers on 3 Study Parameters 15% for VC measurements, and 78 15% and 0.37 (95% CI: 0.16 to 0.58) for PISA measurements. Figure 4 shows the absolute and percentage distribution of substantial (raw agreement 80%), 100% 90% 80% 70% 60% 50% 40% 30% 20% 10% 0% 4 (25%) 5 (31%) VC (%) PISA (%) Jet Size (%) Patient Patient Patient Patient Patient Patient Patient Patient Patient Patient Patient Patient Patient Patient Patient Patient Overall Abbreviations as in Table 1. 7 (44%) 5 (31%) 4 (25%) 7 (44%) 2 (12%) 8 (50%) Jet Area Vena Contracta EROA Poor Fair Substantial 6 (38%) Figure 4. Distribution of Overall Raw Interobserver Agreement for Assessment of MR Severity Substantial (raw agreement 80%), fair (raw agreement 60% to 79%), and poor (raw agreement 60%) interobserver agreements are shown for 3 study parameters for 18 observers. Out of 16 patients, substantial agreement was achieved in 44% of cases for mitral regurgitation (MR) jet area, 44% of patients for vena contracta method, and only 38% for effective regurgitant orifice area (EROA) based on proximal isovelocity surface area radius.

6 240 JACC: CARDIOVASCULAR IMAGING, VOL. 3, NO. 3, % 50% 40% 30% 20% 10% 0% 44% 56% Jet Area 44% 44% Vena Contracta Multi Center Single Center 56% 50% EROA Figure 5. Distribution of Substantial Interobserver Agreement Among Echocardiologists Practicing in a Single Center and Multiple Centers Eighteen cardiologists practicing at 11 different institutions in the U.S., Japan, and Israel assessed mitral regurgitation (MR) severity using 3 methods in 16 patients. In addition, interobserver agreement for assessment of MR severity was compared among the 6 echocardiologists practicing within a single institution to the agreement of the echocardiologists from multiple institutions. There was a similar, suboptimal rate of substantial interobserver agreement (raw agreement 80%) for all 3 color flow Doppler parameters among interpreters from both single center and multicenter interpreters. fair (raw agreement 60% to 79%), and poor (raw agreement 60%) agreement for 3 study parameters. Raw agreement 80% was observed only in 7 (44%) patients for jet area based assessment. In this subgroup, cumulative kappa coefficient was 0.72 (95% CI: 0.68 to 0.76). Substantial agreement for VC was achieved also in 7 (44%) cases, whereas kappa in this subgroup was 0.61 (95% CI: 0.58 to 0.64). For PISA measurement, substantial agreement was present in 6 (38%) patients, kappa 0.85 (95% CI: 0.84 to 0.86). The difference was not significant among the 3 study parameters. In the rest of the cases, the agreement was fair or poor. As shown in Figure 5, separate analysis of interobserver agreement among interpreters practicing in a single institution and those from multiple centers demonstrated that the proportion of raw agreement 80% was insignificantly different for all 3 study parameters, including jet area: 56% for single institution versus 44% for multiple institutions (p 0.72). For VC, raw agreement 80% was same for physicians practicing in single center versus multiple centers at 44% (p 1.0), and for EROA measurement by PISA, raw agreement 80% between the 2 groups of observers was 56% versus 50% of the patients (p 0.99). Similarly there was no significant difference in the proportion of fair or poor agreements for all 3 study methods. Predictors of substantial interobserver agreement. To define the source of heterogeneous agreement on MR severity, etiologic and echocardiographic variables that may limit the accuracy of assessment for each study method were included in univariate and multivariate analysis. Table 3 shows the list of the variables evaluated for each study method as well as their value to predict raw agreement 80%. The only significant univariate predictor of raw agreement 80% for the jet area based method was functional etiology (p 0.039). An eccentric jet had an insignificant influence on interobserver agreement. Multivariate analysis did not identify Table 3. Univariate and Multivariate Analysis of Morphological and Etiologic Predictors of Substantial Interobserver Agreement for Jet Area, VC, and PISA Suboptimal Agreement (Raw Agreement <80%) Substantial Agreement (Raw Agreement >80%) Univariate p Value Multivariate p Value Jet Area MR jet, eccentric/central 50/50 17/ NS Etiology, degenerative/functional 67/33 0/ NS VC MR jet, eccentric/central 89/11 29/ NS Effective MR orifice identifiable, yes/no 22/78 71/ Etiology, degenerative/functional 67/33 29/71 NS NS 30% pansystolic variation of VC width, yes/no 78/22 33/67 NS NS EROA by PISA MR jet, eccentric/central 90/10 17/ PISA spherical, yes/no 70/30 50/ NS Etiology, degenerative/functional 70/30 17/ NS 30% pansystolic variation of PISA radius, yes/no 80/20 20/ NS EROA effective regurgitant orifice area; other abbreviations as in Table 1.

7 JACC: CARDIOVASCULAR IMAGING, VOL. 3, NO. 3, any significant predictor of raw agreement 80% (Table 3). In univariate analysis, the statistically significant predictors for raw agreement 80% for VC were central MR (p 0.013) as well as an identifiable effective regurgitant orifice (p 0.049). Whereas in the multivariate analysis, only the measure of an identifiable effective regurgitant orifice showed a significant predictive power of raw agreement 80% (p 0.035) (Table 3). For the PISA radius measurement, the presence of a central MR jet (p 0.003), fixed proximal flow convergence (p 0.025), and functional etiology (p 0.049) were statistically significant univariate variables for prediction of raw agreement 80%. By multivariate analysis, central regurgitant jet morphology was the only significant predictor of raw interobserver agreement 80% (p 0.02) (Table 3). DISCUSSION This is the first multicenter study to evaluate the interobserver agreement of the quantitative parameters of VC width and PISA to differentiate severe from nonsevere MR. We found that classification of MR as severe as opposed to nonsevere using the quantitative CFD parameters of VC and PISA yielded only fair interobserver agreement (kappa: 0.28 to 0.37). The interobserver agreement for qualitative assessment for identifying severe from nonsevere MR was similar to the quantitative methods (kappa: 0.32). Our study group was composed of clinically experienced, practicing echocardiologists from 11 different academic institutions. Furthermore, we found that the interobserver agreement among echocardiologists practicing and instructing within the same institution was similar to the multicenter interobserver agreement and inferior to previously reported studies from single institutions validating the use of PISA and VC (3,6 11). The VC width and EROA calculated by PISA are both affected by valve morphology and color flow jet characteristics. Incorporation of echocardiographic and etiologic variables in univariate and multivariate analysis revealed some of the sources of disagreement in our study. Various echocardiographic parameters were found to be significant in predicting good agreement for each study method in the univariate analysis. However, the presence of a central regurgitant jet was the only independent discriminator between suboptimal (raw agreement 80%) and substantial reproducibility (raw agreement 80%) for PISA radius measurement. In addition, the identification of an effective regurgitant orifice was the single multivariate predictor of raw agreement 80% for VC measurement. Depending on whether observers use standardized measurements in an echocardiographic core laboratory, in a rigorously controlled research setting, or whether the MR grade is assessed by multiple enrolling sites with multiple echocardiologists, the rate of agreement is markedly different. Reliability of MR classification was reported in the EVEREST I (Endovascular Valve Edge-to-Edge Repair Study) trial. Two qualitative parameters CFD jet characteristics and pulmonary vein flow and 4 quantitative parameters VC width, regurgitant volume, regurgitant fraction, and EROA were evaluated. Parameters were integrated to form composite MR grade. Individual parameters and composite MR severity were found to be reproducible (15). However, considerable disagreement was reported in MR severity grading among echocardiogram readers in the Acorn Clinical Trial (16). All studies were interpreted to show significant MR at enrolling sites, but the core laboratory found that 41% of patients did not have significant MR: 7.4 % of patients had no detectable MR, 10.6% had mild MR, and 23.3% had moderate MR. Thomas et al. (17) proposed an MR index of 6 different indicators of MR: jet penetration into the left atrium, PISA radius, continuous wave jet intensity, pulmonary artery pressure, pulmonary venous flow pattern, and left atrial size. However, there was still a considerable overlap between moderate and severe MR (17). There are several potential explanations for the limited reproducibility for the assessment of MR severity. Qualitative assessment of mitral regurgitation based on jet area varies on any given still frame and may thus be mischaracterized due to the frameby-frame change in jet size. Whereas the eye rapidly integrates the change in jet area over time, this type of visual estimation can be highly subjective and varies among observers assessment. The etiology of MR, the mitral valve morphology, and the regurgitant jet characteristics can further compound the MR assessment (4,5). Sources of error in the measurement of PISA include the presence of an eccentric jet, nonhemispheric geometry of proximal flow convergence, imprecise identification of regurgitant orifice (Fig. 2), and dynamic changes of PISA radius throughout systole (6,7). As with PISA, inherent characteristics of MR can influence

8 242 JACC: CARDIOVASCULAR IMAGING, VOL. 3, NO. 3, 2010 the ability to accurately determine the VC width. The limitations of VC include an eccentric MR jet, dynamic VC, and inadequate visualization of any of the 3 components of VC (Fig. 3): proximal flow acceleration, the VC, and the downstream expansion of the jet (3,4). The American Society of Echocardiography 2003 guidelines for the evaluation of valvular regurgitation emphasize an integrated approach for the classification of MR severity (2). However, in a subsequent large retrospective study in which severity of MR was quantified by Doppler echocardiography, 198 patients with an EROA greater than 0.40 cm 2 had a 4% per year risk of cardiac death during a mean follow-up period of 2.7 years (18). These findings largely contributed to the recent American College of Cardiology/American Heart Association 2008 guideline (1) recommendation to consider mitral valve surgery for asymptomatic patients with severe MR. Given the current recommendations for surgery on asymptomatic patients with severe MR, it is crucial to accurately differentiate severe from nonsevere MR. However, our study demonstrates that not only qualitative CFD but also quantitative CFD parameters have limited reproducibility and thus may be suboptimal in the clinical setting. We believe that the findings of our study, which identifies the potential difficulties in reliability to differentiate severe from nonsevere MR, support the concept of Gaasch and Meyer (19), namely to question the diagnosis of severe chronic MR when little or no left ventricular or left atrial enlargement is found. Study limitations. The relatively small number of patients studied (n 16) is a limitation. However, there were 18 observers and consequently each study parameter was assessed over 200 times. Small sample size may result in overfitted models. However, it will be practically difficult to have 18 cardiologists evaluate MR in a bigger sample size by 3 different methods, although we do realize that it would be ideal to have a bigger sample size. We were attempting to differentiate severe from nonsevere MR, and we have not assessed entire spectrum of MR severity. Had patients with mild MR been included in this study, the interobserver agreement may have been better. The absence of a true gold standard for MR assessment is a potential limitation for any study as it precludes the evaluation of the accuracy of the interpretations. In the absence of such a gold standard, substantial variation exists in the classification of MR as severe in the same patient depending on the method used. These differences limit raw agreement rate maximums to an extent that readers may not appreciate. Clinical implications. As color Doppler flow methods have limited interobserver agreement, the classification of MR as severe and clinical decision making in patients with MR should incorporate the use of additional less equivocal and more reproducible parameters such as mitral inflow pattern, MR jet continuous Doppler profile, mitral inflow pattern, pulmonary venous flow, and mitral valve morphology, as well as left ventricular and left atrial dimensions and left ventricular systolic function and pulmonary artery systolic pressure as recommended by the American Society of Echocardiography (2). CONCLUSIONS The presence of a central MR jet improves the reproducibility of EROA assessment by PISA and the ability to identify the effective regurgitant orifice significantly enhances interobserver agreement of VC assessment. The VC, PISA, and CFD regurgitant jet based assessments of MR grade have substantial interobserver agreement. Use of the VC and PISA method in routine clinical practice, and for clinical decision making based solely on EROA calculation in asymptomatic MR patients may be problematic. Reprint requests and correspondence: Dr. Robert J. Siegel, 8700 Beverly Boulevard, Room 5623, Los Angeles, California siegel@cshs.org. REFERENCES 1. Bonow RO, Carabello BA, Chatterjee K, et al focused update incorporated into the ACC/AHA 2006 guidelines for the management of patients with valvular heart disease: a report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines (Writing Committee to develop guidelines for the management of patients with valvular heart disease). J Am Coll Cardiol 2008;52: e Zoghbi WA, Enriquez-Sarano M, Foster E, et al., on behalf of American Society of Echocardiography. Recommendations for evaluation of the severity of native valvular regurgitation with two-dimensional and Doppler echocardiography. J Am Soc Echocardiogr 2003;16: Hall SA, Brickner ME, Willett DL, Irani WN, Afridi I, Grayburn PA. Assessment of mitral regurgitation severity by Doppler color flow mapping of the vena contracta. Circulation 1997;95: Roberts BJ, Grayburn PA. Color flow imaging of vena contracta in mitral regurgitation: technical considerations. J Am Soc Echocardiogr 2003; 16:

9 JACC: CARDIOVASCULAR IMAGING, VOL. 3, NO. 3, Simpson IA, Shiota T, Gharib M, Sahn DJ. Current status of flow convergence for clinical applications: is it a leaning tower of PISA? J Am Coll Cardiol 1996;27: Schwammenthal E, Chen C, Benning F, Block M, Breithardt G, Levine RA. Dynamics of mitral regurgitant flow and orifice area. Physiologic application of the proximal flow convergence method: clinical data and experimental testing. Circulation 1994;90: Buck T, Plicht B, Kahlert P, Schenk IM, Hunold P, Erbel R. Effect of dynamic flow rate and orifice area on mitral regurgitant stroke volume quantification using the proximal isovelocity surface area method. J Am Coll Cardiol 2008;52: Bargiggia GS, Tronconi L, Sahn DJ, et al. A new method for quantitation of mitral regurgitation based on color flow Doppler imaging of flow convergence proximal to regurgitant orifice. Circulation 1991;84: Rivera JM, Vandervoort PM, Thoreau DH, Levine RA, Weyman AE, Thomas JD. Quantification of mitral regurgitation with the proximal flow convergence method: a clinical study. Am Heart J 1992;124: Enriquez-Sarano M, Seward JB, Bailey KR, Tajik AJ. Effective regurgitant orifice area: a noninvasive Doppler development of an old hemodynamic concept. J Am Coll Cardiol 1994;23: Fehske W, Omran H, Manz M, Köhler J, Hagendorff A, Lüderitz B. Color-coded Doppler imaging of the vena contracta as a basis for quantification of pure mitral regurgitation. Am J Cardiol 1994;73: Fleiss, JL. Statistical Methods for Rates and Proportions. 3rd edition. Hoboken, NJ: John Wiley & Sons, Randolph JJ. Free-marginal multirater kappa: an alternative to Fleiss fixedmarginal multirater kappa. Paper presented at: Joensuu University Learning and Instruction Symposium 2005; October 14 and 15, 2005; Joensuu, Finland. 14. Brennan RL, Prediger DJ. Coefficient kappa: some uses, misuses, and alternatives. Educ Psychol Meas 1981;41: Foster E, Wasserman HS, Gray W, et al. Quantitative assessment of severity of mitral regurgitation by serial echocardiography in a multicenter clinical trial of percutaneous mitral valve repair. Am J Cardiol 2007;100: Acker MA, Bolling S, Shemin R, et al. Mitral valve surgery in heart failure: insights from the Acorn Clinical Trial. J Thorac Cardiovasc Surg 2006; 132: Thomas L, Foster E, Hoffman JI, Schiller NB. The mitral regurgitation index: an echocardiographic guide to severity. J Am Coll Cardiol 1999;33: Enriquez-Sarano M, Avierinos JF, Messika-Zeitoun D, et al. Quantitative determinants of the outcome of asymptomatic mitral regurgitation. N Engl J Med 2005;352: Gaasch WG, Meyer TE. Left ventricular response to mitral regurgitation: implications for management. Circulation 2008;118: Key Words: mitral valve y regurgitation y echocardiography.

PISA Evaluation of Mitral Regurgitation. Raymond Graber, MD Cardiac Anesthesia Group University Hospitals Case Medical Center 4/07/2011

PISA Evaluation of Mitral Regurgitation. Raymond Graber, MD Cardiac Anesthesia Group University Hospitals Case Medical Center 4/07/2011 PISA Evaluation of Mitral Regurgitation Raymond Graber, MD Cardiac Anesthesia Group University Hospitals Case Medical Center 4/07/2011 Introduction Evaluation of MR. What is PISA? Physiologic basis Issues

More information

New 3D Quantification of Mitral Regurgitation Severity. Judy Hung, MD Cardiac Ultrasound Laboratory Massachusetts General Hospital Boston, MA

New 3D Quantification of Mitral Regurgitation Severity. Judy Hung, MD Cardiac Ultrasound Laboratory Massachusetts General Hospital Boston, MA New 3D Quantification of Mitral Regurgitation Severity Judy Hung, MD Cardiac Ultrasound Laboratory Massachusetts General Hospital Boston, MA No Financial Disclosures No off label discussion of devices

More information

Valvular Regurgitation: Can We Do Better Than Colour Doppler?

Valvular Regurgitation: Can We Do Better Than Colour Doppler? Valvular Regurgitation: Can We Do Better Than Colour Doppler? A/Prof David Prior St Vincent s Hospital Melbourne Sports Cardiology Valvular Regurgitation Valve regurgitation volume loads the ventricles

More information

Direct Planimetry of Mitral Valve Regurgitation Orifice Area by Real-time 3D Transesophageal Echocardiography

Direct Planimetry of Mitral Valve Regurgitation Orifice Area by Real-time 3D Transesophageal Echocardiography Direct Planimetry of Mitral Valve Regurgitation Orifice Area by Real-time 3D Transesophageal Echocardiography Ertunc Altiok, Sandra Hamada, Silke van Hall, Mehtap Hanenberg, Eva Grabskaya, Michael Becker,

More information

Prof. JL Zamorano Hospital Universitario Ramón y Cajal

Prof. JL Zamorano Hospital Universitario Ramón y Cajal Prof. JL Zamorano Hospital Universitario Ramón y Cajal Should we forget TR? Nath J et al. Impact of tricuspid regurgitation on long-term survival. J Am Coll Cardiol. 2004; 43:405-409 Why is it difficult

More information

Comparison of Vena Contracta Width by Multiplane Transesophageal Echocardiography With Quantitative Doppler Assessment of Mitral Regurgitation

Comparison of Vena Contracta Width by Multiplane Transesophageal Echocardiography With Quantitative Doppler Assessment of Mitral Regurgitation Comparison of Vena Contracta Width by Multiplane Transesophageal Echocardiography With Quantitative Doppler Assessment of Mitral Regurgitation Sheila K. Heinle, MD, Shelley A. Hall, MD, M. Elizabeth Brickner,

More information

How to assess ischaemic MR?

How to assess ischaemic MR? ESC 2012 How to assess ischaemic MR? Luc A. Pierard, MD, PhD, FESC, FACC Professor of Medicine Head, Department of Cardiology University Hospital Sart Tilman, Liège ESC 2012 No conflict of interest Luc

More information

Improvements in outcomes for heart valve surgery, in particular mitral valve repair, have dictated

Improvements in outcomes for heart valve surgery, in particular mitral valve repair, have dictated Imaging techniques DOPPLER ECHOCARDIOGRAPHIC ASSESSMENT OF VALVAR REGURGITATION c COLOUR Correspondence to: James D Thomas MD, Department of Cardiology, Desk F15, 9500 Euclid Avenue, The Cleveland Clinic

More information

Quantifying Aortic Regurgitation

Quantifying Aortic Regurgitation Quantifying Aortic Regurgitation Linda D. Gillam, MD, MPH Morristown Medical Center Dorothy and Lloyd Huck Chair Cardiovascular Medicine Atlantic Health System No Disclosures 1 Valve Dysfunction Functional

More information

True morphology of mitral regurgitant flow assessed by three- dimensional transesophageal echocardiography

True morphology of mitral regurgitant flow assessed by three- dimensional transesophageal echocardiography DOI: 10.1111/echo.13395 ORIGINAL INVESTIGATION True morphology of mitral regurgitant flow assessed by three- dimensional transesophageal echocardiography Martin Lombardero M.D. Ruth Henquin D.L.S.H.T.M.,

More information

Mitral regurgitation (MR) is a

Mitral regurgitation (MR) is a Review Article Hellenic J Cardiol 2013; 54: 448-454 3D Vena Contracta Area to Quantify Severity of Mitral Regurgitation: A Practical New Tool? Dimitrios Maragiannis, Stephen H. Little The Methodist DeBakey

More information

Hemodynamic Assessment. Assessment of Systolic Function Doppler Hemodynamics

Hemodynamic Assessment. Assessment of Systolic Function Doppler Hemodynamics Hemodynamic Assessment Matt M. Umland, RDCS, FASE Aurora Medical Group Milwaukee, WI Assessment of Systolic Function Doppler Hemodynamics Stroke Volume Cardiac Output Cardiac Index Tei Index/Index of myocardial

More information

Uncommon Doppler Echocardiographic Findings of Severe Pulmonic Insufficiency

Uncommon Doppler Echocardiographic Findings of Severe Pulmonic Insufficiency Uncommon Doppler Echocardiographic Findings of Severe Pulmonic Insufficiency Rahul R. Jhaveri, MD, Muhamed Saric, MD, PhD, FASE, and Itzhak Kronzon, MD, FASE, New York, New York Background: Two-dimensional

More information

MITRAL REGURGITATION ECHO PARAMETERS TOOL

MITRAL REGURGITATION ECHO PARAMETERS TOOL Comprehensive assessment of qualitative and quantitative parameters, along with the use of standardized nomenclature when reporting echocardiographic findings, helps to better define a patient s MR and

More information

Marti McCulloch, BS, MBA, RDCS, FASE Houston, Texas

Marti McCulloch, BS, MBA, RDCS, FASE Houston, Texas Marti McCulloch, BS, MBA, RDCS, FASE Houston, Texas Mitral Regurgitation What to Expect Review Specific Signs of Severity Supportive Signs of Severity Qualitative Parameters Structural Doppler Quantitative

More information

Disclosures Rebecca T. Hahn, MD, FASE

Disclosures Rebecca T. Hahn, MD, FASE The New ASE Guidelines for Native Valvular Regurgitation Mitral Regurgitation The New ASE Guidelines: Role of 2D/3D and CMR (With caveats and comments from R. Hahn) William A. Zoghbi MD, FASE, MACC Professor

More information

Exercise-Induced Changes in Degenerative Mitral Regurgitation

Exercise-Induced Changes in Degenerative Mitral Regurgitation Journal of the American College of Cardiology Vol. 56, No. 4, 2010 2010 by the American College of Cardiology Foundation ISSN 0735-1097/$36.00 Published by Elsevier Inc. doi:10.1016/j.jacc.2009.12.073

More information

aortic regurgitation, vena contracta area, vena contracta width, live three-dimensional echocardiography

aortic regurgitation, vena contracta area, vena contracta width, live three-dimensional echocardiography RESEARCH FROM THE UNIVERSITY OF ALABAMA AT BIRMINGHAM Assessment of Aortic Regurgitation by Live Three-Dimensional Transthoracic Echocardiographic Measurements of Vena Contracta Area: Usefulness and Validation

More information

Diagnostic Value of Vena Contracta Area in the Quantification of Mitral Regurgitation Severity by Color Doppler 3D Echocardiography

Diagnostic Value of Vena Contracta Area in the Quantification of Mitral Regurgitation Severity by Color Doppler 3D Echocardiography Diagnostic Value of Vena Contracta Area in the Quantification of Mitral Regurgitation Severity by Color Doppler 3D Echocardiography Xin Zeng, MD, PhD; Robert A. Levine, MD; Lanqi Hua, RDCS; Eleanor L.

More information

What Degree of MR Deserves Surgical or Transcatheter Intervention, and How Should It Be Assessed?

What Degree of MR Deserves Surgical or Transcatheter Intervention, and How Should It Be Assessed? What Degree of MR Deserves Surgical or Transcatheter Intervention, and How Should It Be Assessed? Robert J. Siegel, M.D., FACC Nov. 14-15, 2017, Beverly Hills Director, Cardiac Non-Invasive Laboratory

More information

Chapter 20. JACC Cardiovasc Imaging 2009;2:

Chapter 20. JACC Cardiovasc Imaging 2009;2: Chapter 20 Quantification of functional mitral regurgitation by real-time 3D echocardiography: comparison with 3D velocity-encoded cardiac magnetic resonance N Ajmone Marsan, J JM Westenberg, C Ypenburg,

More information

Quantification of Functional Mitral Regurgitation by Real-Time 3D Echocardiography

Quantification of Functional Mitral Regurgitation by Real-Time 3D Echocardiography JACC: CARDIOVASCULAR IMAGING VOL. 2, NO. 11, 2009 2009 BY THE AMERICAN COLLEGE OF CARDIOLOGY FOUNDATION ISSN 1936-878X/09/$36.00 PUBLISHED BY ELSEVIER INC. DOI:10.1016/j.jcmg.2009.07.006 ORIGINAL RESEARCH

More information

Echocardiography: Guidelines for Valve Quantification

Echocardiography: Guidelines for Valve Quantification Echocardiography: Guidelines for Echocardiography: Guidelines for Chamber Quantification British Society of Echocardiography Education Committee Richard Steeds (Chair), Gill Wharton (Lead Author), Jane

More information

Functional Mitral Regurgitation

Functional Mitral Regurgitation Club 35 - The best in heart valve disease - Functional Mitral Regurgitation Steven Droogmans, MD, PhD UZ Brussel, Jette, Belgium 08-12-2011 Euroecho & other Imaging Modalities 2011 No conflicts of interest

More information

MITRAL VALVE PATHOLOGY WITH TRICUSPID REGURGITATION (AND PHT)

MITRAL VALVE PATHOLOGY WITH TRICUSPID REGURGITATION (AND PHT) UNIVERSITY OF PADUA, SCHOOL OF MEDICINE Department of Cardiac,Thoracic and Vascular Sciences Padua, Italy MITRAL VALVE PATHOLOGY WITH TRICUSPID REGURGITATION (AND PHT) Luigi P. Badano**, MD, PhD, FESC,

More information

Primary Mitral Regurgitation

Primary Mitral Regurgitation EURO VALVE Madrid News from Valves Guidelines 2012: What s new and Why? Primary Mitral Regurgitation Luc A. Pierard, MD, PhD Professor of Medicine Head of the Department of Cardiology Heart Valve Clinic,

More information

Percutaneous Mitral Valve Repair: What Can We Treat and What Should We Treat

Percutaneous Mitral Valve Repair: What Can We Treat and What Should We Treat Percutaneous Mitral Valve Repair: What Can We Treat and What Should We Treat Innovative Procedures, Devices & State of the Art Care for Arrhythmias, Heart Failure & Structural Heart Disease October 8-10,

More information

Professors Carpentier and McGoon Mechanism, resulting from the disease Severity of regurgitation, resulting from the mechanism Echo

Professors Carpentier and McGoon Mechanism, resulting from the disease Severity of regurgitation, resulting from the mechanism Echo Professors Carpentier and McGoon Mechanism, resulting from the disease Severity of regurgitation, resulting from the mechanism Echo define the mechanism, quantify the regurgitation severity CP1293058-3

More information

Milind Desai Christine Jellis Teerapat Yingchoncharoen Editors. An Atlas of Mitral Valve Imaging

Milind Desai Christine Jellis Teerapat Yingchoncharoen Editors. An Atlas of Mitral Valve Imaging Milind Desai Editors An Atlas of Mitral Valve Imaging 123 An Atlas of Mitral Valve Imaging Milind Desai Editors An Atlas of Mitral Valve Imaging Editors Milind Desai Department of Cardiovascular Medicine

More information

An understanding of the many factors involved in the

An understanding of the many factors involved in the Atrioventricular Valve Dysfunction: Evaluation by Doppler and Cross-Sectional Ultrasound Norman H. Silverman, MD, and Doff B. McElhinney, MD Division of Pediatric Cardiology, Department of Pediatrics,

More information

What are the best diagnostic tools to quantify aortic regurgitation?

What are the best diagnostic tools to quantify aortic regurgitation? What are the best diagnostic tools to quantify aortic regurgitation? Agnès Pasquet, MD, PhD Pôle de Recherche Cardiovasculaire Institut de Recherche Expérimentale et Clinique Université catholique de Louvain

More information

What echo measurements are key prior to MitraClip?

What echo measurements are key prior to MitraClip? APHP CHU Bichat - Claude Bernard What echo measurements are key prior to MitraClip? Eric Brochet,MD Cardiology Department Hopital Bichat Paris France No disclosure Conflict of interest Case 69 y.o man

More information

CHAPTER 4 AN EFFICACIOUS APPROACH FOR THE QUANTIFICATION OF MITRAL REGURGITATION USING IMAGE PROCESSING AND PROXIMAL FLOW CONVERGENCE METHOD

CHAPTER 4 AN EFFICACIOUS APPROACH FOR THE QUANTIFICATION OF MITRAL REGURGITATION USING IMAGE PROCESSING AND PROXIMAL FLOW CONVERGENCE METHOD CHAPTER 4 AN EFFICACIOUS APPROACH FOR THE QUANTIFICATION OF MITRAL REGURGITATION USING IMAGE PROCESSING AND PROXIMAL FLOW CONVERGENCE METHOD 4.1. Introduction Mitral Regurgitation also called Mitral Insufficiency

More information

The Doppler Examination. Katie Twomley, MD Wake Forest Baptist Health - Lexington

The Doppler Examination. Katie Twomley, MD Wake Forest Baptist Health - Lexington The Doppler Examination Katie Twomley, MD Wake Forest Baptist Health - Lexington OUTLINE Principles/Physics Use in valvular assessment Aortic stenosis (continuity equation) Aortic regurgitation (pressure

More information

The diagnosis of mitral regurgitation (MR) caused

The diagnosis of mitral regurgitation (MR) caused J Vet Intern Med 2014;28:1206 1213 Assessment of Mitral Regurgitation Severity by Doppler Color Flow Mapping of the Vena Contracta in Dogs M. Di Marcello, E. Terzo, C. Locatelli, V. Palermo, E. Sala, E.

More information

Echocardiography. Guidelines for Valve and Chamber Quantification. In partnership with

Echocardiography. Guidelines for Valve and Chamber Quantification. In partnership with Echocardiography Guidelines for Valve and Chamber Quantification In partnership with Explanatory note & references These guidelines have been developed by the Education Committee of the British Society

More information

Usefulness of 3D-PISA as compared to guideline endorsed parameters for mitral regurgitation quantification

Usefulness of 3D-PISA as compared to guideline endorsed parameters for mitral regurgitation quantification DOI 10.1007/s10554-014-0496-7 ORIGINAL PAPER Usefulness of 3D-PISA as compared to guideline endorsed parameters for mitral regurgitation quantification Frank P. Schmidt Theresa Gniewosz Alexander Jabs

More information

Guidelines in perspective?

Guidelines in perspective? EuroValve 2016 Challenges in the management Secondary MR Guidelines in perspective? Luc A. Pierard, MD, PhD Professor of Medicine Head of the Department of Cardiology, Liège, Belgium Heart Valve Clinic,

More information

Quantitative Assessment of Mitral Regurgitation

Quantitative Assessment of Mitral Regurgitation JACC: CARDIOVASCULAR IMAGING VOL. 5, NO. 11, 2012 2012 BY THE AMERICAN COLLEGE OF CARDIOLOGY FOUNDATION ISSN 1936-878X/$36.00 PUBLISHED BY ELSEVIER INC. http://dx.doi.org/10.1016/j.jcmg.2012.07.013 STATE-OF-THE-ART

More information

M itral regurgitation (MR) is the most commonly

M itral regurgitation (MR) is the most commonly iv11 Assessment of mitral regurgitation T Irvine, X K Li, D J Sahn, A Kenny... M itral regurgitation (MR) is the most commonly encountered valve lesion in modern clinical practice. 1 The range of pathologies

More information

ASCeXAM / ReASCE. Practice Board Exam Questions Monday Morning

ASCeXAM / ReASCE. Practice Board Exam Questions Monday Morning ASCeXAM / ReASCE Practice Board Exam Questions Monday Morning Ultrasound Physics Artifacts Doppler Physics Imaging, Knobology, and Artifacts Echocardiographic Evaluation of the RV Tricuspid and Pulmonary

More information

PART II ECHOCARDIOGRAPHY LABORATORY OPERATIONS ADULT TRANSTHORACIC ECHOCARDIOGRAPHY TESTING

PART II ECHOCARDIOGRAPHY LABORATORY OPERATIONS ADULT TRANSTHORACIC ECHOCARDIOGRAPHY TESTING PART II ECHOCARDIOGRAPHY LABORATORY OPERATIONS ADULT TRANSTHORACIC ECHOCARDIOGRAPHY TESTING STANDARD - Primary Instrumentation 1.1 Cardiac Ultrasound Systems SECTION 1 Instrumentation Ultrasound instruments

More information

AATS Annual Meeting Seattle, WA Irving Kron, M.D. Professor and Chairman Department of Surgery University of Virginia Hospital Charlottesville,

AATS Annual Meeting Seattle, WA Irving Kron, M.D. Professor and Chairman Department of Surgery University of Virginia Hospital Charlottesville, AATS Annual Meeting Seattle, WA Irving Kron, M.D. Professor and Chairman Department of Surgery University of Virginia Hospital Charlottesville, Virginia AATS Ischemic MR Guideline Writing Group Roster

More information

LUST trial. Echocardiography USER S MANUAL

LUST trial. Echocardiography USER S MANUAL LUST trial Echocardiography USER S MANUAL Rosa Sicari, Luna Gargani Ins1tute of Clinical Physiology Na1onal Council of Research, Pisa, Italy Parameters required (1) Aortic root Measurement of aortic root

More information

Aortic Regurgitation and Aortic Aneurysm - Epidemiology and Guidelines -

Aortic Regurgitation and Aortic Aneurysm - Epidemiology and Guidelines - Reconstruction of the Aortic Valve and Root - A Practical Approach - Aortic Regurgitation and Aortic Aneurysm Wednesday 14 th September - 9.45 Practice must always be founded on sound theory. Leonardo

More information

Doppler Basic & Hemodynamic Calculations

Doppler Basic & Hemodynamic Calculations Doppler Basic & Hemodynamic Calculations August 19, 2017 Smonporn Boonyaratavej MD Division of Cardiology, Department of Medicine Chulalongkorn University Cardiac Center, King Chulalongkorn Memorial Hospital

More information

Journal of the American College of Cardiology Vol. 44, No. 9, by the American College of Cardiology Foundation ISSN /04/$30.

Journal of the American College of Cardiology Vol. 44, No. 9, by the American College of Cardiology Foundation ISSN /04/$30. Journal of the American College of Cardiology Vol. 44, 9, 2004 2004 by the American College of Cardiology Foundation ISSN 0735-1097/04/$30.00 Published by Elsevier Inc. doi:10.1016/j.jacc.2004.04.062 Relation

More information

Aortic stenosis (AS) is common with the aging population.

Aortic stenosis (AS) is common with the aging population. New Insights Into the Progression of Aortic Stenosis Implications for Secondary Prevention Sanjeev Palta, MD; Anita M. Pai, MD; Kanwaljit S. Gill, MD; Ramdas G. Pai, MD Background The risk factors affecting

More information

Cover Page. The handle holds various files of this Leiden University dissertation.

Cover Page. The handle   holds various files of this Leiden University dissertation. Cover Page The handle http://hdl.handle.net/1887/21650 holds various files of this Leiden University dissertation. Author: Shanks, Miriam Title: Evolving imaging techniques for the assessment of cardiac

More information

Clinical Outcome of Tricuspid Regurgitation. David Messika-Zeitoun

Clinical Outcome of Tricuspid Regurgitation. David Messika-Zeitoun Clinical Outcome of Tricuspid Regurgitation David Messika-Zeitoun I have financial relationships to disclose Consultant for: Edwards, Symetis and Valtech Tricuspid Regurgitation is a Common Finding Tricuspid

More information

Failure of Guideline Adherence for Intervention in Patients With Severe Mitral Regurgitation

Failure of Guideline Adherence for Intervention in Patients With Severe Mitral Regurgitation Journal of the American College of Cardiology Vol. 54, No. 9, 2009 2009 by the American College of Cardiology Foundation ISSN 0735-1097/09/$36.00 Published by Elsevier Inc. doi:10.1016/j.jacc.2009.03.079

More information

Organic mitral regurgitation

Organic mitral regurgitation The best in heart valve disease Organic mitral regurgitation Ewa Szymczyk Department of Cardiology Medical University of Lodz, Poland I have nothing to declare Organic mitral regurgitation leaflet abnormality

More information

Titel Kardiologie-SG.ch hot topics in heart failure and mitral regurgitation

Titel Kardiologie-SG.ch hot topics in heart failure and mitral regurgitation Titel Kardiologie-SG.ch hot topics in heart failure and mitral regurgitation where and how to quantify mitral regurgitation: Echolab, Cathlab or MRI? Philipp K. Haager, St. Gallen Measuring mitral regurgitation?

More information

Acute Effects of Cardiac Resynchronization Therapy on Functional Mitral Regurgitation in Advanced Systolic Heart Failure

Acute Effects of Cardiac Resynchronization Therapy on Functional Mitral Regurgitation in Advanced Systolic Heart Failure Journal of the American College of Cardiology Vol. 41, No. 5, 2003 2003 by the American College of Cardiology Foundation ISSN 0735-1097/03/$30.00 Published by Elsevier Science Inc. doi:10.1016/s0735-1097(02)02937-6

More information

Echocardiographic evaluation of mitral stenosis

Echocardiographic evaluation of mitral stenosis Echocardiographic evaluation of mitral stenosis Euroecho 2011 Philippe Unger, MD, FESC Erasme Hospital, ULB, Brussels, Belgium I have nothing to declare EuroHeart Survey Etiology of single native left-sided

More information

Chapter 24: Diagnostic workup and evaluation: eligibility, risk assessment, FDA guidelines Ashwin Nathan, MD, Saif Anwaruddin, MD, FACC Penn Medicine

Chapter 24: Diagnostic workup and evaluation: eligibility, risk assessment, FDA guidelines Ashwin Nathan, MD, Saif Anwaruddin, MD, FACC Penn Medicine Chapter 24: Diagnostic workup and evaluation: eligibility, risk assessment, FDA guidelines Ashwin Nathan, MD, Saif Anwaruddin, MD, FACC Penn Medicine Mitral regurgitation, regurgitant flow between the

More information

Mitral regurgitation (MR) is the most common

Mitral regurgitation (MR) is the most common The EVEREST Percutaneous Mitral Leaflet Repair Trials An overview of the safety and efficacy data of the MitraClip system for treating mitral regurgitation. BY ALICE PERLOWSKI, MD, AND TED E. FELDMAN,

More information

Appendix II: ECHOCARDIOGRAPHY ANALYSIS

Appendix II: ECHOCARDIOGRAPHY ANALYSIS Appendix II: ECHOCARDIOGRAPHY ANALYSIS Two-Dimensional (2D) imaging was performed using the Vivid 7 Advantage cardiovascular ultrasound system (GE Medical Systems, Milwaukee) with a frame rate of 400 frames

More information

Secondary MR joint with the mitral academy. What is new in our understanding of this disease? Luc Pierard University Hospital, Liège

Secondary MR joint with the mitral academy. What is new in our understanding of this disease? Luc Pierard University Hospital, Liège Secondary MR joint with the mitral academy What is new in our understanding of this disease? Luc Pierard University Hospital, Liège Faculty disclosure Luc Pierard I have no financial relationships to disclose.

More information

Revealing new insights. irotate electronic rotation and xplane adjustable biplane imaging. Ultrasound cardiology. irotate and xplane

Revealing new insights. irotate electronic rotation and xplane adjustable biplane imaging. Ultrasound cardiology. irotate and xplane Ultrasound cardiology irotate and xplane Revealing new insights irotate electronic rotation and xplane adjustable biplane imaging Annemien van den Bosch and Jackie McGhie Department of Cardiology, Erasmus

More information

Left atrial function. Aliakbar Arvandi MD

Left atrial function. Aliakbar Arvandi MD In the clinic Left atrial function Abstract The left atrium (LA) is a left posterior cardiac chamber which is located adjacent to the esophagus. It is separated from the right atrium by the inter-atrial

More information

Pulsed Wave Doppler and Color Flow Doppler Evaluation in Healthy Dogs and Dogs with Cardiac Disease

Pulsed Wave Doppler and Color Flow Doppler Evaluation in Healthy Dogs and Dogs with Cardiac Disease Cloud Publications International Journal of Advanced Veterinary Science and Technology 2016, Volume 5, Issue 2, pp. 256-265, Article ID Sci-446 ISSN 2320-3595 Research Article Open Access Pulsed Wave Doppler

More information

Asymptomatic Valvular Disease:

Asymptomatic Valvular Disease: Asymptomatic Valvular Disease: Can Echocardiography Help You Decide When to Intervene? Neil J. Weissman, MD MedStar Health Research Inst at MedStar Washington Hospital Center & Professor of Medicine Georgetown

More information

Quantification of MR

Quantification of MR Valvular Regurgitation: Putting the New Guidelines into Practice James D. Thomas, MD, FACC, FASE, FESC Director, Center for Heart Valve Disease Bluhm Cardiovascular Institute Professor of Medicine, Feinberg

More information

In the clinical management of patients with ventricular

In the clinical management of patients with ventricular Quantitative Assessment of Severity of Ventricular Septal Defect by Three-Dimensional Reconstruction of Color Doppler Imaged Vena Contracta and Flow Convergence Region Masahiro Ishii, MD; Kanoko Hashino,

More information

Catheter-based mitral valve repair MitraClip System

Catheter-based mitral valve repair MitraClip System Percutaneous Mitral Valve Repair: Results of the EVEREST II Trial William A. Gray MD Director of Endovascular Services Associate Professor of Clinical Medicine Columbia University Medical Center The Cardiovascular

More information

Policy #: 222 Latest Review Date: March 2009

Policy #: 222 Latest Review Date: March 2009 Name of Policy: MRI Phase-Contrast Flow Measurement Policy #: 222 Latest Review Date: March 2009 Category: Radiology Policy Grade: Active Policy but no longer scheduled for regular literature reviews and

More information

Clinical material and methods. Departments of 1 Cardiology and 2 Anatomy, Gaziantep University, School of Medicine, Gaziantep, Turkey

Clinical material and methods. Departments of 1 Cardiology and 2 Anatomy, Gaziantep University, School of Medicine, Gaziantep, Turkey Interatrial Block and P-Terminal Force: A Reflection of Mitral Stenosis Severity on Electrocardiography Murat Yuce 1, Vedat Davutoglu 1, Cayan Akkoyun 1, Nese Kizilkan 2, Suleyman Ercan 1, Murat Akcay

More information

NT-proBNP as a Marker of Left Ventricular Dysfunction in Chronic Asymptomatic Mitral Regurgitation

NT-proBNP as a Marker of Left Ventricular Dysfunction in Chronic Asymptomatic Mitral Regurgitation NT-proBNP as a Marker of Left Ventricular Dysfunction in Chronic Asymptomatic Mitral Regurgitation Srikornruth Panyaratanakul 1, Tanarat Choon-ngarm 2, Wilai Puavilai 2, Saowaluk Prompongsa 2, Donpichit

More information

Three-Dimensional P3 Tethering Angle at the Heart of Future Surgical Decision Making in Ischemic Mitral Regurgitation

Three-Dimensional P3 Tethering Angle at the Heart of Future Surgical Decision Making in Ischemic Mitral Regurgitation Accepted Manuscript Three-Dimensional P3 Tethering Angle at the Heart of Future Surgical Decision Making in Ischemic Mitral Regurgitation Wobbe Bouma, MD PhD, Robert C. Gorman, MD PII: S0022-5223(18)32805-8

More information

Journal of the American College of Cardiology Vol. 42, No. 3, by the American College of Cardiology Foundation ISSN /03/$30.

Journal of the American College of Cardiology Vol. 42, No. 3, by the American College of Cardiology Foundation ISSN /03/$30. Journal of the American College of Cardiology Vol. 42, No. 3, 2003 2003 by the American College of Cardiology Foundation ISSN 0735-1097/03/$30.00 Published by Elsevier Inc. doi:10.1016/s0735-1097(03)00649-1

More information

Ioannis Alexanian, MD, PhD Department of Cardiology General Hospital of Chest Diseases Sotiria Athens

Ioannis Alexanian, MD, PhD Department of Cardiology General Hospital of Chest Diseases Sotiria Athens MITRAL REGURGITATION IN PATIENT WITH SEVERE AORTIC VALVE STENOSIS Ioannis Alexanian, MD, PhD Department of Cardiology General Hospital of Chest Diseases Sotiria Athens I HAVE NOTHING TO DECLARE Management

More information

Quantification of Mitral Regurgitation by Automated Cardiac Output Measurement: Experimental and Clinical Validation

Quantification of Mitral Regurgitation by Automated Cardiac Output Measurement: Experimental and Clinical Validation 1074 JACC Vol. 32, No. 4 NEW METHODS Quantification of Mitral Regurgitation by Automated Cardiac Output Measurement: Experimental and Clinical Validation JING PING SUN, MD, FACC, XING SHENG YANG, MD, PHD,

More information

Chronic Primary Mitral Regurgitation

Chronic Primary Mitral Regurgitation Chronic Primary Mitral Regurgitation The Case For Early Surgical Intervention William K. Freeman, MD, FACC, FASE DISCLOSURES Relevant Financial Relationship(s) None Off Label Usage None Watchful Waiting......

More information

Who will Benefit from Percutaneous Management of Mitral Regurgitation? An Imaging Guide to Management

Who will Benefit from Percutaneous Management of Mitral Regurgitation? An Imaging Guide to Management Who will Benefit from Percutaneous Management of Mitral Regurgitation? An Imaging Guide to Management James D. Thomas, M.D., F.A.C.C. Department of Cardiovascular Medicine Heart and Vascular Institute

More information

8/31/2016. Mitraclip in Matthew Johnson, MD

8/31/2016. Mitraclip in Matthew Johnson, MD Mitraclip in 2016 Matthew Johnson, MD 1 Abnormal Valve Function Valve Stenosis Obstruction to valve flow during that phase of the cardiac cycle when the valve is normally open. Hemodynamic hallmark - pressure

More information

Comments restricted to Sapien and Corevalve 9/12/2016. Disclosures: Core Lab contracts with Edwards Lifesciences, Middlepeak, Medtronic

Comments restricted to Sapien and Corevalve 9/12/2016. Disclosures: Core Lab contracts with Edwards Lifesciences, Middlepeak, Medtronic Para-ValvularRegurgitation post TAVR: Predict, Prevent, Quantitate, Manage Linda D. Gillam, MD, MPH, FACC, FASE Chair, Department of Cardiovascular Medicine Morristown Medical Center/Atlantic Health System

More information

ECHOCARDIOGRAPHY DATA REPORT FORM

ECHOCARDIOGRAPHY DATA REPORT FORM Patient ID Patient Study ID AVM - - Date of form completion / / 20 Initials of person completing the form mm dd yyyy Study period Preoperative Postoperative Operative 6-month f/u 1-year f/u 2-year f/u

More information

Prof. Patrizio LANCELLOTTI, MD, PhD Heart Valve Clinic, University of Liège, CHU Sart Tilman, Liège, BELGIUM

Prof. Patrizio LANCELLOTTI, MD, PhD Heart Valve Clinic, University of Liège, CHU Sart Tilman, Liège, BELGIUM The Patient with Aortic Stenosis and Mitral Regurgitation Prof. Patrizio LANCELLOTTI, MD, PhD Heart Valve Clinic, University of Liège, CHU Sart Tilman, Liège, BELGIUM Aortic Stenosis + Mitral Regurgitation?

More information

EVALUATION OF CHRONIC MITRAL REGURGITATION: ASSESSING MECHANISMS AND QUANTIFYING SEVERITY 2018 STRUCTURAL HEART DISEASE CONFERENCE June 1, 2018

EVALUATION OF CHRONIC MITRAL REGURGITATION: ASSESSING MECHANISMS AND QUANTIFYING SEVERITY 2018 STRUCTURAL HEART DISEASE CONFERENCE June 1, 2018 1 EVALUATION OF CHRONIC MITRAL REGURGITATION: ASSESSING MECHANISMS AND QUANTIFYING SEVERITY 2018 STRUCTURAL HEART DISEASE CONFERENCE June 1, 2018 David A. Orsinelli, MD, FACC, FASE Professor, Internal

More information

JOINT MEETING 2 Tricuspid club Chairpersons: G. Athanassopoulos, A. Avgeropoulou, M. Khoury, G. Stavridis

JOINT MEETING 2 Tricuspid club Chairpersons: G. Athanassopoulos, A. Avgeropoulou, M. Khoury, G. Stavridis JOINT MEETING 2 Tricuspid club Chairpersons: G. Athanassopoulos, A. Avgeropoulou, M. Khoury, G. Stavridis Similarities and differences in Tricuspid vs. Mitral Valve Anatomy and Imaging. Echo evaluation

More information

EDITOR S PICK CURRENT STATUS OF FULLY AUTOMATED SOFTWARE WITH THREE-DIMENSIONAL ECHOCARDIOGRAPHY FOR THE QUANTIFICATION OF LEFT VENTRICULAR FUNCTION

EDITOR S PICK CURRENT STATUS OF FULLY AUTOMATED SOFTWARE WITH THREE-DIMENSIONAL ECHOCARDIOGRAPHY FOR THE QUANTIFICATION OF LEFT VENTRICULAR FUNCTION ITOR S PICK This paper, courtesy of Yang and Takeuchi, provides a timely and well-considered update on the current status of fully-automated software with three-dimensional echocardiography for quantifying

More information

Effect of Mitral Inflow Pattern on Diagnosis of Severe Mitral Regurgitation in Patients with Chronic Organic Mitral Regurgitation

Effect of Mitral Inflow Pattern on Diagnosis of Severe Mitral Regurgitation in Patients with Chronic Organic Mitral Regurgitation http://dx.doi.org/10.4250/jcu.2013.21.4.165 without severe MR. 2) On the basis of a limited number of studies, American Society of Echocardiography (ASE) guidelines stated that, In severe MR without stenosis,

More information

Relation of interatrial duration and p wave terminal force as a novel indicator of severe

Relation of interatrial duration and p wave terminal force as a novel indicator of severe European Review for Medical and Pharmacological Sciences 2012; 16: 1576-1581 Relation of interatrial duration and p wave terminal force as a novel indicator of severe mitral regurgitation M.A. ELBEY 1,

More information

Determinants of Exercise-Induced Changes in Mitral Regurgitation in Patients With Coronary Artery Disease and Left Ventricular Dysfunction

Determinants of Exercise-Induced Changes in Mitral Regurgitation in Patients With Coronary Artery Disease and Left Ventricular Dysfunction Journal of the American College of Cardiology Vol. 42, No. 11, 2003 2003 by the American College of Cardiology Foundation ISSN 0735-1097/03/$30.00 Published by Elsevier Inc. doi:10.1016/j.jacc.2003.04.002

More information

Ultrasound 10/1/2014. Basic Echocardiography for the Internist. Mechanical (sector) transducer Piezoelectric crystal moved through a sector sweep

Ultrasound 10/1/2014. Basic Echocardiography for the Internist. Mechanical (sector) transducer Piezoelectric crystal moved through a sector sweep Ultrasound Basic Echocardiography for the Internist Carol Gruver, MD, FACC UT Erlanger Cardiology Mechanical wave of compression and rarefaction Requires a medium for transmission Ultrasound frequency

More information

ASE Guidelines on Aortic Regurgitation What Do I Measure? Case Studies

ASE Guidelines on Aortic Regurgitation What Do I Measure? Case Studies ASE Guidelines on Aortic Regurgitation What Do I Measure? Case Studies Mitral Regurgitation The New ASE Guidelines: Role of 2D/3D and CMR William A. Zoghbi MD, FASE, MACC Professor and Chairman, Department

More information

Methods XIAODONG ZHOU, MD, MICHAEL JONES, MD,* TAKAHIRO SHIOTA, MD, IZUMI YAMADA, MD,* DAG TEIEN, MD, DAVID J. SAHN, MD, FACC

Methods XIAODONG ZHOU, MD, MICHAEL JONES, MD,* TAKAHIRO SHIOTA, MD, IZUMI YAMADA, MD,* DAG TEIEN, MD, DAVID J. SAHN, MD, FACC JACC Vol. 30, No. 5 November 1, 1997:1393 8 1393 Vena Contracta Imaged by Doppler Color Flow Mapping Predicts the Severity of Eccentric Mitral Regurgitation Better Than Color Jet Area: A Chronic Animal

More information

When should we intervene surgically in pediatric patient with MR?

When should we intervene surgically in pediatric patient with MR? When should we intervene surgically in pediatric patient with MR? DR.SAUD A. BAHAIDARAH CONSULTANT, PEDIATRIC CARDIOLOGY ASSISTANT PROFESSOR OF PEDIATRICS HEAD OF CARDIOLOGY AND CARDIAC SURGERY UNIT KAUH

More information

The Patient with Atrial Fibrilation

The Patient with Atrial Fibrilation Assessment of Diastolic Function The Patient with Atrial Fibrilation Assoc. Prof. Adriana Ilieşiu, FESC University of Medicine Carol Davila Bucharest, Romania Associated Conditions with Atrial Fibrillation

More information

Research Presentation June 23, Nimish Muni Resident Internal Medicine

Research Presentation June 23, Nimish Muni Resident Internal Medicine Research Presentation June 23, 2009 Nimish Muni Resident Internal Medicine Research Question In adult patients with repaired Tetralogy of Fallot, how does Echocardiography compare to MRI in evaluating

More information

Mitral Regurgitation

Mitral Regurgitation Mitral Regurgitation Focus on Percutaneous Repair Steven J. Yakubov, MD FACC FSCAI System Chief, Structural Heart Diseaese, OhioHealth John H. McConnell Chair of Advanced Structural Heart Disease Medical

More information

Valvular Heart Disease

Valvular Heart Disease Valvular Heart Disease Roman M. Sniecinski, MD, FASE Associate Professor of Anesthesiology Emory University School of Medicine Learning Objectives Review the major pathophysiology of the most common heart

More information

3D Echo for Evaluation of Tricuspid Regurgitation Jong-Min Song, MD, PhD

3D Echo for Evaluation of Tricuspid Regurgitation Jong-Min Song, MD, PhD 3D Echo for Evaluation of Tricuspid Regurgitation Jong-Min Song, MD, PhD Asan Medical Center University of Ulsan College of Medicine Seoul, Korea Causes of TR Primary causes (25%) Rheumatic Myxomatous

More information

Cover Page. The handle holds various files of this Leiden University dissertation.

Cover Page. The handle   holds various files of this Leiden University dissertation. Cover Page The handle http://hdl.handle.net/1887/38522 holds various files of this Leiden University dissertation. Author: Ewe, See Hooi Title: Aortic valve disease : novel imaging insights from diagnosis

More information

Echo in Asymptomatic Mitral and Aortic Regurgitation

Echo in Asymptomatic Mitral and Aortic Regurgitation 2017 ASE Florida Orlando, FL October 9, 2017 10:40 11:00 PM 20 min Grand Harbor Ballroom South Echo in Asymptomatic Mitral and Aortic Regurgitation Muhamed Sarić MD, PhD, MPA Director of Noninvasive Cardiology

More information

Current recommendations underscore the use of qualitative

Current recommendations underscore the use of qualitative Quantification of Chronic Functional Mitral Regurgitation by Automated 3-Dimensional Peak and Integrated Proximal Isovelocity Surface Area and Stroke Volume Techniques Using Real-Time 3-Dimensional Volume

More information

CASE REPORT: DOUBLE ORIFICE MITRAL VALVE WITH CLEFT IN ANTERIOR LEAFLET OF DOMINANT VALVE IN AN AFRO-CARIBBEAN

CASE REPORT: DOUBLE ORIFICE MITRAL VALVE WITH CLEFT IN ANTERIOR LEAFLET OF DOMINANT VALVE IN AN AFRO-CARIBBEAN CASE REPORT: DOUBLE ORIFICE MITL VAE WITH CLEFT IN ANTERIOR LEAFLET OF DOMINANT VAE IN AN AFRO-CARIBBEAN Disclosure: No potential conflict of interest. Received: 27.08.13 Accepted: 23.06.14 Citation: EMJ

More information

25 different brand names >44 different models Sizes mm

25 different brand names >44 different models Sizes mm Types of Prosthetic Valves BIOLOGIC STENTED Porcine xenograft Pericardial xenograft STENTLESS Porcine xenograft Pericardial xenograft Homograft (allograft) Autograft PERCUTANEOUS MECHANICAL Bileaflet Single

More information